
TSI GROUP CO., LTD. — Investor Relations & Filings
TSI Group Co., Ltd. is a global developer and manufacturer of functional ingredients and finished dosage forms for the dietary supplement, pharmaceutical, and food and beverage sectors. The company specializes in the research, development, and large-scale production of high-quality bioactive compounds. Key product categories include joint health ingredients such as glucosamine and chondroitin, as well as proprietary muscle health and metabolic health solutions like HMB and PEAK ATP. TSI Group maintains advanced manufacturing facilities and quality control systems to ensure compliance with international standards. The organization focuses on providing science-based ingredients supported by clinical research to global brand owners and manufacturers. Its core capabilities span from raw material sourcing and chemical synthesis to specialized formulation and finished product manufacturing.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 技源集团股份有限公司2025年年度股东会会议资料 | 2026-05-22 | Chinese | |
| 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-05-15 | Chinese | |
| 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-05-11 | Chinese | |
| 技源集团股份有限公司关于回购股份事项前十大股东和前十大无限售条件股东持股情况的报告 | 2026-05-07 | Chinese | |
| 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-05-07 | Chinese | |
| 技源集团2025年度报告摘要 | 2026-04-27 | Chinese |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46868153 | 技源集团股份有限公司2025年年度股东会会议资料 | 2026-05-22 | Chinese | ||
| 46364759 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-05-15 | Chinese | ||
| 45016886 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-05-11 | Chinese | ||
| 44267612 | 技源集团股份有限公司关于回购股份事项前十大股东和前十大无限售条件股东持股情况的报告 | 2026-05-07 | Chinese | ||
| 44267577 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-05-07 | Chinese | ||
| 39593617 | 技源集团2025年度报告摘要 | 2026-04-27 | Chinese | ||
| 39593616 | 东方证券股份有限公司关于技源集团股份有限公司2025年度日常关联交易执行情况和2026年度日常关联交易预计的核查意见 | 2026-04-27 | Chinese | ||
| 39593612 | 技源集团关于使用部分闲置募集资金进行现金管理的公告 | 2026-04-27 | Chinese | ||
| 39593607 | 技源集团2025年度董事会审计委员会履职报告 | 2026-04-27 | Chinese | ||
| 39593602 | 技源集团关于2026年第一季度主要经营数据公告 | 2026-04-27 | Chinese | ||
| 39593600 | 技源集团关于2025年度日常关联交易执行情况和2026年度日常关联交易预计的公告 | 2026-04-27 | Chinese | ||
| 39593599 | 技源集团关于召开2025年年度股东会的通知 | 2026-04-27 | Chinese | ||
| 39593596 | 东方证券股份有限公司关于技源集团股份有限公司2025年度持续督导现场检查报告 | 2026-04-27 | Chinese | ||
| 39593588 | 技源集团关于公司使用部分自有资金进行投资理财的公告 | 2026-04-27 | Chinese | ||
| 39593578 | 技源集团关于2025年度计提资产减值准备的公告 | 2026-04-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
TSI GROUP CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57547/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57547 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57547 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57547 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57547}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TSI GROUP CO., LTD. (id: 57547)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.